Vision Marine Technologies Inc. filed a registration statement with the SEC, with ThinkEquity acting as the sole book-running manager.
3 reports, 2 independent
Updated Aug 19
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vision Marine Technologies Inc. filed a registration statement with the SEC, with ThinkEquity acting as the sole book-running manager.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Vision Marine Technologies Inc. filed its registration statement with the SEC, managed by ThinkEquity.1 source
The company filed its registration statement on August 15, 2025.1 source
Biovie filed its registration statement with the SEC on August 12, 2025.1 source
Keep exploring
The entities involved
-
ThinkEquity
US investment banking firm
Nothing else this week.
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.
Coverage
Newest first; wire copies grouped- ACCESS NewswireVision Marine Technologies Inc. Announces Closing of Public Offering MONTRÉAL, QC / ACCESS Newswire / August 18, 2025 / Vision Marine Technologies Inc. (the "Company", "Vision Marine", "we", "us", "o
- ACCESS NewswireVision Marine Technologies, Inc. Announces Pricing of Public Offering MONTRÉAL, QUEBEC / ACCESS Newswire / August 15, 2025 / Vision Marine Technologies Inc. (the "Company", "Vision Marine", "we", "us
- GlobeNewswireBioVie Inc. Announces Closing of $12 Million Public Offering CARSON CITY, Nev., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage comp